Carlos R. Bachier, MD | Authors

Articles

Evaluating the Feasibility of Liso-cel Administration in the Outpatient Setting

April 22, 2020

Carlos R. Bachier, MD, discusses how an analysis of 3 clinical trials evaluating the efficacy of lisocabtagene maraleucel demonstrated the feasibility of outpatient administration of chimeric antigen receptor T-cell therapy.